Back to Search
Start Over
Inotersen therapy of transthyretin amyloid cardiomyopathy
- Source :
- Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 27(1)
- Publication Year :
- 2019
-
Abstract
- Background: Cardiomyopathy is a major cause of death in patients with systemic transthyretin amyloidosis. Long term effect of therapy designed to inhibit hepatic production of the amyloid precursor...
- Subjects :
- Male
Pathology
medicine.medical_specialty
Amyloid
Cardiomyopathy
Oligonucleotides
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Internal Medicine
medicine
Humans
Term effect
In patient
Cause of death
Aged
Amyloid Neuropathies, Familial
biology
business.industry
Amyloidosis
Middle Aged
medicine.disease
Transthyretin
biology.protein
Female
business
Amyloid cardiomyopathy
Cardiomyopathies
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 17442818
- Volume :
- 27
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
- Accession number :
- edsair.doi.dedup.....3a182105c4a0d1a1cda077f502ad993a